The Effects of Axitinib plus Tislelizumab in the Treatment of Advanced Renal Cell Carcinoma

OBJECTIVE: To study and analyze the clinical efficacy of axitinib combined with tislelizumab in the treatment of advanced renal cell carcinoma and its effects on renal function and serum cytokines. METHODS: Totally 49 patients with advanced renal cancer treated in our hospital from November 2018 to...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhixin, Chen, Jiaqi, Li, Qianyu, Li, Na, Yu, Jing, Liu, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970885/
https://www.ncbi.nlm.nih.gov/pubmed/35368892
http://dx.doi.org/10.1155/2022/2700166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970885/
https://www.ncbi.nlm.nih.gov/pubmed/35368892
http://dx.doi.org/10.1155/2022/2700166

Ejemplares similares